{"nctId":"NCT00855309","briefTitle":"Acyclovir in Preventing Herpes Simplex Virus Infection in Patients With Neutropenia","startDateStruct":{"date":"2008-11"},"conditions":["Herpes Simplex"],"count":112,"armGroups":[{"label":"Arm I","type":"EXPERIMENTAL","interventionNames":["Drug: acyclovir sodium"]},{"label":"Arm II","type":"EXPERIMENTAL","interventionNames":["Drug: acyclovir sodium"]}],"interventions":[{"name":"acyclovir sodium","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Be 18 years of age or older.\n* Receiving treatment in inpatient oncology services at Wake Forest University Baptist Medical Center\n* Receiving chemotherapy or have received chemotherapy within the past 2 weeks\n* Seropositive herpes simplex virus (HSV)-1 or HSV-2 immunoglobulin antibody assay\n* Creatinine clearance ≥ 50 mL/min\n* Intravenous acyclovir sodium therapy is deemed necessary by the physician based upon clinical judgement (i.e., mucositis, vomiting, decreased GI absorption)\n\nExclusion Criteria:\n\n* Pregnant or nursing\n* Hypersensitivity to acyclovir sodium\n* High tumor burden (i.e., WBC \\> 50,000/mm\\^3 at admission)\n* Neutropenic, defined as one of the following:\n* ANC \\< 500/mm\\^3\n* ANC \\< 1,000/mm\\^3 with a predicted decrease to 500/mm\\^3\n* Active HSV infection, as evidenced by any of the following:\n* Positive HSV cultures\n* Oral lesions\n* Receiving 5 mg/kg acyclovir sodium every 8 hours","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"120 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Participants Experiencing Incidence of Nephrotoxicity, Defined as a Serum Creatinine ≥ 2 Times the Patient's Baseline","description":null,"paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"3","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":56},"commonTop":["Nephrotoxicity"]}}}